Skip to content

Drug interactions

Lapatinib + Solifenacin

Severity: Moderate

Lapatinib and Solifenacin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib inhibits CYP3A4 and may increase solifenacin concentrations, and both drugs can prolong the QT interval. Together this may increase the risk of QT-related arrhythmia and antimuscarinic adverse effects.

What this interaction means in plain words

Lapatinib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Solifenacin belongs to Genitourinary.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition by lapatinib plus additive QT prolongation.

What to do

Obtain a baseline ECG and check electrolytes, correcting any abnormalities. Limit solifenacin to the lower dose range and monitor for QT prolongation and anticholinergic effects.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Solifenacin?

MediHelp rates the interaction as moderate. Lapatinib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib inhibits CYP3A4 and may increase solifenacin concentrations, and both drugs can prolong the QT interval. Together this may increase the risk of QT-related arrhythmia and antimuscarinic adverse effects.

How serious is the interaction between Lapatinib and Solifenacin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and check electrolytes, correcting any abnormalities. Limit solifenacin to the lower dose range and monitor for QT prolongation and anticholinergic effects.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in